Predictive value of XPD polymorphisms on platinum-based chemotherapy in non-small cell lung cancer: a systematic review and meta-analysis.
<h4>Background</h4>The correlation between xeroderma pigmentosum group D (XPD) polymorphisms (Lys751Gln and Asp312Asn) and clinical outcomes of non-small cell lung cancer (NSCLC) patients, who received platinum-based chemotherapy (Pt-chemotherapy), is still inconclusive. This meta-analys...
Saved in:
Main Authors: | Mantang Qiu, Xin Yang, Jingwen Hu, Xiangxiang Ding, Feng Jiang, Rong Yin, Lin Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0072251 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.
by: Huiping Xue, et al.
Published: (2012-01-01) -
Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer
by: I. S. Krysanov, et al.
Published: (2023-11-01) -
Significance of Platinum‐Based Chemotherapy With Programmed Death‐1 Blockade in Limited Disease Small Cell Lung Cancer: A Retrospective Study
by: Ayako Shiono, et al.
Published: (2025-07-01) -
Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis.
by: Lou Qian Zhang, et al.
Published: (2012-01-01) -
XRCC3 Thr241Met polymorphism and clinical outcomes of NSCLC patients receiving platinum-based chemotherapy: a systematic review and meta-analysis.
by: Xiao-yong Shen, et al.
Published: (2013-01-01)